Teleflex (TFX) to Acquire Market Leader in Hemostatic Products
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Teleflex (TFX) Tops Q3 EPS by 22c, Revenues Beat
October 29, 2020 6:40 AM EDTTeleflex (NYSE: TFX) reported Q3 EPS of $2.46, $0.22 better than the analyst estimate of $2.24. Revenue for the quarter came in at $628.3 million versus the consensus estimate of $619.4 million.
Third Quarter Revenues of $628.3 million, down 3.1% versus Prior Year Period on an As-Reported basis; down 4.1% on a Constant Currency basisThird Quarter GAAP Diluted EPS from Continuing Operations of $2.46, Compared to $4.85 in the Prior Year PeriodThird Quarter Adjusted Diluted EPS from Continuing... More